Back to User profile » Mr Patrick Lefebvre
Papers published by Mr Patrick Lefebvre:
Real-World Maintenance Phase Persistence on Ustekinumab and Adalimumab in Ulcerative Colitis
Zhdanava M, Kachroo S, Shah A, Ding Z, Lefebvre P, Zhao R, Kerner C, Pilon D
Patient Preference and Adherence 2024, 18:809-820
Published Date: 10 April 2024
Real-World Comparison of First-Line Treatment Adherence Between Single-Agent Ibrutinib and Acalabrutinib in Patients with Chronic Lymphocytic Leukemia
Lu X, Emond B, Morrison L, Kinkead F, Lefebvre P, Lafeuille MH, Khan W, Wu LH, Qureshi ZP, Jacobs R
Patient Preference and Adherence 2023, 17:2073-2084
Published Date: 23 August 2023
Impact of COVID-19 Pandemic on Prescribing of Long-Acting Injectable Antipsychotics for Schizophrenia: Results from a United States Prescriber Survey
Zhdanava M, Starr HL, Totev TI, Lefebvre P, Shah A, Sheng K, Pilon D
Neuropsychiatric Disease and Treatment 2022, 18:2003-2019
Published Date: 7 September 2022
Understanding the Health System Conditions Affecting the Use of Long-Acting Injectable Antipsychotics in the Treatment of Schizophrenia in Clinical Practice: A US Healthcare Provider Survey
Zhdanava M, Starr HL, Lefebvre P, Totev TI, Shah A, Sheng K, Pilon D
Neuropsychiatric Disease and Treatment 2022, 18:1479-1493
Published Date: 22 July 2022
Switching and Discontinuation Patterns Among Patients Stable on Originator Infliximab Who Switched to an Infliximab Biosimilar or Remained on Originator Infliximab
Fitzgerald T, Melsheimer R, Lafeuille MH, Lefebvre P, Morrison L, Woodruff K, Lin I, Emond B
Biologics: Targets and Therapy 2021, 15:1-15
Published Date: 6 January 2021
Treatment Patterns and Predictors of Adherence in HIV Patients Receiving Single- or Multiple-Tablet Darunavir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide
Chow W, Donga P, Côté-Sergent A, Rossi C, Lefebvre P, Lafeuille MH, Hardy H, Emond B
Patient Preference and Adherence 2020, 14:2315-2326
Published Date: 23 November 2020
A retrospective study to assess clinical characteristics and time to initiation of open-triple therapy among patients with chronic obstructive pulmonary disease, newly established on long-acting mono- or combination therapy
Mapel D, Laliberté F, Roberts MH, Sama SR, Sundaresan D, Pilon D, Lefebvre P, Duh MS, Patel J
International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1825-1836
Published Date: 21 June 2017
Treatment patterns in Medicaid patients with schizophrenia initiated on a first- or second-generation long-acting injectable versus oral antipsychotic
Pilon D, Joshi K, Tandon N, Lafeuille M, Kamstra RL, Emond B, Lefebvre P
Patient Preference and Adherence 2017, 11:619-629
Published Date: 23 March 2017